TR BioSurgical

TR BioSurgical was a veterinary biomaterials company that developed and commercialized advanced tissue repair and regenerative medicine products. The company's lead product, TR Matrix, was a collagen-based bioscaffold engineered to mimic early-stage connective tissue for use in orthopedic, dermatological, and dental applications. Additionally, the company developed the TR-ClarifEYE glaucoma implant, a surgically implanted device designed to relieve ocular pressure in animals. While the company successfully commercialized several products through partnerships with distributors like IMEX Veterinary, its operations appear to have ceased, with its primary products discontinued from the market.